KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Invested Capital (2016 - 2025)

Historic Invested Capital for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $459.1 million.

  • Medpace Holdings' Invested Capital fell 4439.18% to $459.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $459.1 million, marking a year-over-year decrease of 4439.18%. This contributed to the annual value of $459.1 million for FY2025, which is 4439.18% down from last year.
  • As of Q4 2025, Medpace Holdings' Invested Capital stood at $459.1 million, which was down 4439.18% from $293.6 million recorded in Q3 2025.
  • Medpace Holdings' 5-year Invested Capital high stood at $952.9 million for Q4 2021, and its period low was $172.4 million during Q2 2025.
  • For the 5-year period, Medpace Holdings' Invested Capital averaged around $611.2 million, with its median value being $576.3 million (2023).
  • Per our database at Business Quant, Medpace Holdings' Invested Capital surged by 8717.7% in 2024 and then plummeted by 7742.91% in 2025.
  • Over the past 5 years, Medpace Holdings' Invested Capital (Quarter) stood at $952.9 million in 2021, then crashed by 54.21% to $436.4 million in 2022, then rose by 28.09% to $558.9 million in 2023, then skyrocketed by 47.7% to $825.5 million in 2024, then plummeted by 44.39% to $459.1 million in 2025.
  • Its Invested Capital was $459.1 million in Q4 2025, compared to $293.6 million in Q3 2025 and $172.4 million in Q2 2025.